High SPHK1 expression correlates with aggressive CRC behavior and poor OS, indicating that SPHK1 could serve as a potential prognostic biomarker and therapeutic target for patients with CRC [40]. The gene discussed is SPHK1; the disease is colorectal carcinoma.